---
title: "Shanghai InnoStar Bio-tech Co., Ltd. (688710.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688710.SH.md"
symbol: "688710.SH"
name: "Shanghai InnoStar Bio-tech Co., Ltd."
industry: "Life Sciences Tools and Services"
---

# Shanghai InnoStar Bio-tech Co., Ltd. (688710.SH)

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Location | CN Market |
| Website | [www.innostar.cn](https://www.innostar.cn) |

## Company Profile

Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally. The company offers screening and discovery, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutic...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-28T04:30:13.000Z

**Overall: C (0.56)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 16 / 27 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -26.03% |  |
| Net Profit YoY | -99.86% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 3.49 |  |
| Dividend Ratio | 0.55% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 8.15B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 829.81M |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.01% | D |
| Profit Margin | 0.02% | D |
| Gross Margin | 46.47% | B |

#### Growth Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -26.03% | E |
| Net Profit YoY | -99.86% | E |
| Total Assets YoY | -2.73% | D |
| Net Assets YoY | -0.42% | D |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 405941.47% | A |
| OCF YoY | -26.03% | E |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.26 | D |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 25.17% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai InnoStar Bio-tech Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.01%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "0.02%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "46.47%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "E",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-26.03%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-99.86%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-2.73%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.42%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "405941.47%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-26.03%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "25.17%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | WuXi AppTec (SH.603259) | A | A | C | B | B | B |
| 02 | Pharmaron (SZ.300759) | B | B | C | C | B | B |
| 03 | Chemexpress (SH.688131) | B | A | C | C | B | B |
| 04 | HitGen (SH.688222) | B | B | D | B | B | B |
| 05 | Sepax Technologies (SH.688758) | C | B | E | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 39857.84 | 19/27 | 31886.28 | 148.43 | 46.07 |
| PB | 3.49 | 13/27 | 2.86 | 2.52 | 1.99 |
| PS (TTM) | 9.82 | 20/27 | 7.85 | 6.03 | 4.52 |
| Dividend Yield | 0.55% | 7/27 | 0.76% | 0.71% | 0.57% |

## References

- [Company Overview](https://longbridge.com/en/quote/688710.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688710.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688710.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.